Literature DB >> 12165275

Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection.

Susanne Beckebaum1, Vito R Cicinnati, Grzegorz Dworacki, Jan Müller-Berghaus, Donna Stolz, Jo Harnaha, Theresa L Whiteside, Angus W Thomson, Lina Lu, John J Fung, C Andrew Bonham.   

Abstract

Dendritic cells (DCs) induce and regulate T-cell-mediated immune responses. Circulating precursor (p)DC1 and pDC2 from patients with chronic hepatitis B virus (HBV) infection were quantified by flow cytometry. To assess their function, DC1 were cultured from patients and compared to those of healthy volunteers. HBV patients exhibited a significant decrease in the proportion of freshly isolated pDC1 to pDC2. DC1 propagated from patients showed lower expression of costimulatory molecules and impaired allostimulatory capacity in comparison to controls. After exposure to proinflammatory cytokines, expression of costimulatory molecules, secretion of interleukin-12 (IL-12) and allostimulatory properties increased, but capacity for T-cell stimulation and IL-12 production remained inferior to that of control DCs. HBV-DNA was amplified by polymerase chain reaction in DC1 cultured from all patients. Viral particles were visible in DC1 by electron microscopy. These results suggest that intracellular presence of HBV impairs DC1 functional maturation and subsequent deficits in T-lymphocyte activation may contribute to viral persistence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165275     DOI: 10.1006/clim.2002.5245

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  31 in total

Review 1.  Dissecting the dendritic cell controversy in chronic hepatitis B virus infection.

Authors:  Adam J Gehring; June Ann D'Angelo
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 2.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

Review 3.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

4.  Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study.

Authors:  Min Chen; Yong-Guo Li; Da-Zhi Zhang; Zhi-Yi Wang; Wei-Qun Zeng; Xiao-Feng Shi; Yuan Guo; Shu-Hua Guo; Hong Ren
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.

Authors:  Marjoleine L Op den Brouw; Rekha S Binda; Mark H van Roosmalen; Ulrike Protzer; Harry L A Janssen; Renate G van der Molen; Andrea M Woltman
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

Review 6.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Authors:  Susanne Beckebaum; Vito R Cicinnati; Xia Zhang; Stanislav Ferencik; Andrea Frilling; Hans Grosse-Wilde; Christoph Erich Broelsch; Guido Gerken
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

8.  Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection.

Authors:  S Tavakoli; I Mederacke; S Herzog-Hauff; D Glebe; S Grün; D Strand; S Urban; A Gehring; P R Galle; W O Böcher
Journal:  Clin Exp Immunol       Date:  2007-11-20       Impact factor: 4.330

9.  Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection.

Authors:  Peng-Yuan Zheng; Dong-Yun Zhang; Gao-Feng Lu; Ping-Chang Yang; Yuan-Ming Qi; Bai-Sheng Wang
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

10.  Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B.

Authors:  Gao-Feng Lu; Fu-Ai Tang; Peng-Yuan Zheng; Ping-Chang Yang; Yuan-Ming Qi
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.